Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$5.09 - $9.05 $18,838 - $33,494
-3,701 Reduced 29.04%
9,044 $50,000
Q3 2022

Nov 14, 2022

BUY
$3.5 - $7.2 $44,607 - $91,764
12,745 New
12,745 $82,000
Q1 2022

May 12, 2022

SELL
$6.3 - $8.84 $340,848 - $478,270
-54,103 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$6.02 - $11.43 $325,700 - $618,397
54,103 New
54,103 $451,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $68.2M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.